These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28947296)

  • 21. Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a self-controlled design.
    Ohlmeier MC; Traupe H; Luger TA; Böhm M
    J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):503-7. PubMed ID: 21569118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata.
    Al Bazzal A; Hatami P; Abedini R; Etesami I; Ayanian Z; Ghandi N
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108186. PubMed ID: 34710658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone.
    van der Steen PH; van Baar HM; Happle R; Boezeman JB; Perret CM
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):227-30. PubMed ID: 2007667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of alopecia areata with diphenylcyclopropenone.
    van der Steen PH; van Baar HM; Perret CM; Happle R
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):253-7. PubMed ID: 2007671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
    Inui S; Nakajima T; Toda N; Itami S
    J Dermatol; 2009 Jun; 36(6):323-7. PubMed ID: 19500180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited efficacy of diphenylcyclopropenone in the treatment of alopecia areata: Experience from a Tertiary Healthcare Institution in Singapore.
    Leong WMS; Mok ZR; Chandran NS
    Dermatol Ther; 2020 Nov; 33(6):e14447. PubMed ID: 33098604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective review of diphencyprone in the treatment of alopecia areata.
    Lamb RC; Young D; Holmes S
    Clin Exp Dermatol; 2016 Jun; 41(4):352-8. PubMed ID: 26620737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
    Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM
    Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of alopecia areata with topical sensitizers.
    Sutherland L; Laschinger M; Syed ZU; Gaspari A
    Dermatitis; 2015; 26(1):26-31. PubMed ID: 25581667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of alopecia areata with diphenylcyclopropenone.
    Kietzmann H; Hardung H
    Acta Derm Venereol; 1985; 65(3):274-5. PubMed ID: 2411093
    [No Abstract]   [Full Text] [Related]  

  • 31. Diphencyprone in the treatment of alopecia areata.
    Happle R; Hausen BM; Wiesner-Menzel L
    Acta Derm Venereol; 1983; 63(1):49-52. PubMed ID: 6191489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience.
    El Khoury J; Abd-el-Baki J; Succariah F; Abbas O; Kibbi AG; Kurban M
    Int J Dermatol; 2013 Dec; 52(12):1551-6. PubMed ID: 24134785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of alopecia areata with diphenylcyclopropenone.
    Hull SM; Cunliffe WJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):276-7. PubMed ID: 1552076
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of alopecia areata with diphencyprone.
    Orecchia G; Rabbiosi G
    Dermatologica; 1985; 171(3):193-6. PubMed ID: 4076492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety and efficacy of diphencyprone for the treatment of alopecia areata in children.
    Salsberg JM; Donovan J
    Arch Dermatol; 2012 Sep; 148(9):1084-5. PubMed ID: 22986874
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata.
    Luk NM; Chiu LS; Lee KC; Chau CT; Lee VW; Chang M; Lam YK; Lee HC
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e400-5. PubMed ID: 23057682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata.
    Jang YH; Jung HJ; Moon SY; Lee WJ; Lee SJ; Lee WK; Kim DW
    J Am Acad Dermatol; 2017 Jul; 77(1):170-172.e1. PubMed ID: 28619558
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment for facial alopecia areata: A systematic review with evidence-based analysis.
    Murad A; Bergfeld W
    J Am Acad Dermatol; 2018 Mar; 78(3):601-605. PubMed ID: 28987491
    [No Abstract]   [Full Text] [Related]  

  • 39. Alopecia areata: topical immunotherapy--application and practical problems.
    MacDonald N; Wiseman MC; Shapiro J
    J Cutan Med Surg; 1999 Nov; 3 Suppl 3():S36-40. PubMed ID: 11776938
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
    Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
    J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.